Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs TORM plc (TRMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs TORM plc — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $76.8 (market cap $5.08B), while TORM plc trades at $39.16 (market cap $4.12B). The key difference: Oruka Therapeutics Inc. Common Stock is the larger of the two by market cap, and TORM plc pays a 11.07% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and TORM plc for 23 Days on average.
| ORKA | TRMD | |
|---|---|---|
Market Cap | $5.08B | $4.12B |
Volume | 685,276 | 2,428,655 |
Sector | Health | Industrials |
52-Week High | $113.08 | $41.11 |
52-Week Low | $26.19 | $19.39 |
Typical Hold Time | 0 Days | 23 Days |
Enterprise Value | $4.21B | $4.83B |
Dividend Yield | — | 11.07% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TRMD trades at $41.11, up 0.46% today, with a bullish technical signal from moving averages and strong fundamentals including a P/E of 6.56 and net income margin of 35.52%. Recent earnings showed a Q2 2026 miss but a Q4 2025 beat, while revenue is projected to grow from $1.34B in 2025 to $1.8B in 2026. A $2.40 dividend is scheduled for September 2026, and analyst consensus is unanimously bullish with 3 buy ratings.
The outlook for TRMD is positive due to robust profitability and low valuation, but risks include declining spot rates and insider selling. Upside potential hinges on sustained freight demand, while near-term pressure may arise from earnings volatility and competitive tanker markets. Investors should weigh the high dividend yield against cyclical industry exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About TORM plc
TORM plc is one of the world's largest owners and operators of product tankers, specializing in the transportation of refined oil products like gasoline, jet fuel, and diesel. Operating under its integrated 'One TORM' model, the company maintains a modern, wholly-owned fleet of nearly 90 vessels. It is widely recognized by investors for its aggressive variable dividend policy, which returns a significant portion of its cash flow directly to shareholders during periods of high freight rates.
Read more on TRMD →
